Recent development of pineal melatonin and its receptors in humans

Frontiers of Hormone Research

Volumn 21, Issue , 1996, Pages 133-146

  Pang, S F ^a   Pang, C S ^a   Poon, A M S ^a   Shiu, S Y W ^a   Song, Y ^a   Lee, P P N ^a   Zhao, Y ^a   Liu, Z M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 6844259706     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (73)

1. Reiter RJ: The melatonin rhythm: Both a clock and a calendar. Experientia 1993;49:654-664.
2. Arendt J: The pineal in human physiology and pathology; in Arendt J (ed): Melatonin and the Mammalian Pineal Gland. London, Chapman & Hall, 1995, pp 201-240.
3. Garcia-Patterson A, Puig-Domingo M, Webb SM: Thirty years of human pineal research: Do we know its clinical relevance? J Pineal Res 1996;20:1-6.
4. Vaughan GM, Pelham RW, Pang SF, Laughlin LL, Wilson KN, Sandock KL, Vaughan MK, Koslow SH, Reiter RJ: Nocturnal elevation of plasma melatonin and urinary 5-hydroxyindolacetic acid in young men: Attempts at modification by brief changes in environmental lighting and sleep and by autonomic drugs. J Clin Endocrinol Metab 1976;52:752-764.
5. Vaughan GM: Melatonin in humans. Pineal Res Rev 1984;3:141-201.
6. Pang SF, Lee PPN, Chan YS, Ayre EA: Melatonin secretion and its rhythms in biological fluids; in Yu HS, Reiter RJ (eds): Melatonin: Biosynthesis, Physiological Effects and Clinical Applications. Boca Raton, CRC Press, 1993, pp 129-153.
7. Li Y, Jiang DH, Wang ML, Jiao DR, Pang SF: Rhythms of serum melatonin in patients with spinal transection at the cervical, thoracic or lumbar region. Clin Endocrinol 1989;30:47-56.
8. Pang SF: Melatonin concentrations in blood and pineal gland; in Reiter RJ (ed): Pineal Research Reviews. New York, Liss, 1985, vol 3, pp 115-159.
9. Pang SF, Li Y, Jiang DH, Wang ML, Jiao DR: Acute cerebral hemorrhage changes the nocturnal surge of plasma melatonin in humans. J Pineal Res 1990;9:193-208.
10. Brown GM: Melatonin in psychiatric and sleep disorders: Therapeutic implications. CNS Drug 1995;3:209-226.
11. Waldhauser F, Weisenbacher G, Tatzer E, Gisinger B, Waldhauer M, Schemper M, Frisch H: Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metab 1988;66:648-652.
12. Low LCK, Cheung PT, Cao DR, Wang CCL, Pang SF: Plasma melatonin concentrations in patients with precocious thelarche or precocious puberty; in Reiter RJ Pang SF (eds): Advances in Pineal Research. London, Libbey, 1989, vol 3, pp 287-290.
13. Brown GM, Young SN, Gauthier S, Tsui HW, Grota LJ: Melatonin in human cerebrospinal fluid in daytime: Its origin and variation with age. Life Sci 1979;25:929-936.
14. Iguchi H, Kato KI, Ibayashi H: Age-dependent reduction in serum melatonin concentrations in healthy human subjects. J Clin Endocrinol Metab 1982;55:27-29.
15. Pang SF, Huang C, Ng MT, He ZC: Plasma concentrations of melatonin and N-acetylserotonin in different age groups of human males. Acta Physiol Sin 1985;37:492-496.
16. Pang SF, Chow TC: Increase in plasma levels of melatonin during the preoperative and intraoperative periods of surgery in human males. Acta Physiol Sin 1984;36:506-509.
17. Puig-Domingo M, Rajmil O, Tortosa F, de Leiva A: Role of the pineal hormone melatonin in patients with hypergonadotropic and hypogonadotropic hypogonadisms; in Tang PL, Pang SF, Reiter RJ (eds): Melatonin: A Universal Photoperiodic Signal with Diverse Actions. Front Horm Res. Basel, Karger, 1996, vol 21, pp 186-198.
18. Morita Y, Uchida K, Okamoto N: Melatonin rhythm of Alzheimer patients; in Tang PL, Pang SF, Reiter RJ (eds): Melatonin: A Universal Photoperiodic Signal with Diverse Actions. Front Horm Res. Basel, Karger, 1996, vol 21, pp 180-185.
19. Truer KV, Norman TR, Armstrong SM: Overnight human plasma melatonin, cortisol, prolactin, TSH, under conditions of normal sleep, sleep deprivation, and sleep recovery. J Pineal Res 1996;20: 7-14.
20. Brown GM: Day-night rhythm disturbance, pineal function and human disease. Horm Res 1992; 37(suppl 3):105-111.
21. Reppert SM, Weaver DR, Rivkees SA: Putative melatonin receptors in a human biological clock. Science 1988;24:78-80.
22. Reppert SM, Weaver DR, Ebisawa: Cloning and characterization of mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994;13:1177-1185.
23. Weaver DR, Stehl JH, Stopa EG, Reppert SM: Melatonin receptors in human hypothalamus and pituitary: implications for circadian and reproductive responses to melatonin. J Clin Endocrinol Metab 1993;76:295-301.
24. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP: Light suppresses melatonin secretion in humans. Science 1980;210:1267-1269.
25. Brainard GC, Gaddy JR, Barker FM, Hanifin JP, Rollag MD: Mechanisms in the eye that mediate the biological and therapeutic effects of light in humans; in Wetterberg L (ed): Light and Biological Rhythms in Man. Oxford, Pergamon Press, 1993, pp 29-53.
26. Waldhauser F, Boepple PA. Schemper M, Mansfield MJ, Crowley WF Jr: Serum melatonin in central precocious puberty is lower than in age-matched prepubertal children. J Clin Endocrinol Metab 1991;73:793-796.
27. Arendt J: Melatonin. Clin Endocrinol 1988;29:205-229.
28. Cardinali DP, Cutrera R, Castillón P, García-Bonacho M, Selgas L, Esquifino AI: Circadian organization of immune response in rat submaxillary lymph nodes: A site for melatonin action; in Tang PL, Pang SF, Reiter RJ (eds): Melatonin: A Universal Photoperiodic Signal with Diverse Actions. Front: Horm Res. Basel, Karger, 1996, vol 21, pp 60-70.
29. Carlberg C, Wiesenberg I: The orphan receptor family RZR/ROR, melatonin and 5-lipoxygenase: an unexpected relationship. J Pineal Res 1995;18:171-178.
30. Morgan PJ, Barrett P, Howell HE, Helliwell R: Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem Int 1994;24:101-146.
31. Masson-Pévet M, Gauer F, Recio J: Melatonin receptors, pars tuberalis and photoperiodic response; in Tang PL, Pang SF, Reiter RJ (eds): Melatonin: A Universal Photoperiodic Signal with Diverse Actions. Front Horm Res. Basel, Karger, vol 21, pp 84-89.
32. 125I]iodomelatonin binding sites in the brain of the human fetus. Neurosci Lett 1991;130:229-232.
33. Fauteck JD, Lerchl A, Bergmann M, Moller M, Fraschini F, Wittkowski W, Stankov B: The adult human cerebellum is a target of the neuroendocrine system involved in the circadian timing. Neurosci Lett 1994;179:60-64.
34. 125I]iodomelatonin binding sites in infant cerebellum of sudden infant death syndrome and non-sudden infant death syndome. Neurosci Lett 1995;197:154-158.
35. Nash MS, Osborne NN: Pertussis toxin-sensitive melatonin receptors negatively coupled to adenylate cyclase associated with cultured human and rat retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1995;36:95-102.
36. Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA, Gusella JF: Molecular characterization of a second melatonin receptor expressed in human retina and brain: The Me11b melatonin receptor. Proc Natl Acad Sci 1995;92:9734-8738.
37. 125I]- labelled iodomelatonin-binding sites in the testes and ovaries of the chicken (Callus domesticus). J Endocrinol 1992;133:5-11.
38. Ayre EA, Pang SF: Putative melatonin receptors in the testis and ovary: Attestation of a direct action of melatonin on the gonads. Biol Signals 1994;3:71-84.
39. Yie SM, Niles LP, Younglai EV: Melatonin receptors on human granulosa cell membranes. J Clin Endocrinol Metab 1995;80:1747-1749.
40. Webley GE, Luck MR: Melatonin directly stimulates the secretion of progesterone by human and bovine granulosa cells in vitro. J Reprod Fert 1986;78:711-717.
41. Brzezinski A, Fibich T, Cohen M, Shenker JG, Laufer N: Effects of melatonin on progesterone production by human granulosa lutein cells in culture. Fertil Steril 1992;58:526-529.
42. 125I]iodomelatonin binding sites in the rat epididymis. J Pineal Res 1994;17:195-201.
43. Koopman MG, Minors DS, Waterhouse JM: Urinary and renal circadian rhythms; in Arendt J, Minors DS, Waterhouse JM (eds): Biological Rhythms in Clinical Practice. London, Wright, 1989, pp 83-98.
44. 125I] iodomelatonin binding sites in the human kidney and the effect of guanosine 5′-O-(-3-thiotriphosphate). J Clin Endocrinol Metab 1995;80:1560-1565.
45. 125I]Iodomelatonin binding sites in mammalian and avian kidneys. Biol Signals 1993;2:207-220.
46. 125I]Iodomelatonin-binding sites in the chicken kidney: Characterization and comparison to other avian species. Biol Signals 1992;1:313-321.
47. Song Y, Lee PJPN, Chan CWY, Brown GM, Pang SF, Silverman M: Recent advances in renal melatonin receptors; in Tang PL, Pang SF, Reiter RJ (eds): Melatonin: A Universal Photoperiodic Signal with Diverse Actions. Front Horm Res. Basel, Karger, 1996, vol 21, pp 115-122.
48. Tsuda T, Ide M, Igo M: Influences of season and of temperature, photoperiod, and subcutaneous melatonin infusion on the glomerular filtration rate of ewes. J Pineal Res 1995;19:166-172.
49. Pontoire C, Bernard M, Silvain C, Collin JP, Voisin P: Characterization of melatonin binding sites in chicken and human intestines. Eur J Pharmacol 1993;247:111-118.
50. 125I]iodomelatonin binding sites in the human colon. Endocrinol Res 1996;22:77-94.
51. Konakchieva R, Kyurkchiev S, Kehayov I, Taushanova P, Kanchev L: Selective effect of methoxyindoles on the lymphocyte proliferation and melatonin binding to activated human lymphoid cells. J Neuroimmunol 1995;63:125-132.
52. Ying SW, Niles LP, Crocker C: Human malignant melanoma cells express high-affinity receptors for melatonin: Antiproliferative effects of melatonin and 6-chloromelatonin. Eur J Pharmacol 1993;246:89-96.
53. Gupta D: The role of melatonin in human pathophysiology; in Yu HS, Reiter RJ (eds): Melatonin: Biosynthesis, Physiological Effects and Clincial Applications. Boca Raton, CRC Press, 1993, pp 417-445.
54. Blask DE: Melatonin in oncology; in Yu HS, Reiter RJ (eds); Melatonin: Biosynthesis, Physiological Effects and Clinical Applications. Boca Raton, CRC Press, 1993, pp 447-494.
55. Lemus-Wilson A, Kelly PA, Blask DE: Melatonin blocks the stimulatory effects of prolactin on human breast cancer cell growth in culture. Br J Cancer 1995;72:1435-1440.
56. Lopez-Gonzalez MA, Calvo JR, Osuma C, Guerrero JM: Interaction of melatonin with human lymphocytes: Evidence for binding sites coupled to potentiation of cyclic AMP stimulated by vasoactive intestinal peptide and activation of cyclic GMP. J Pineal Res 1992;12:97-104.
57. Loepz-Gonzalez MA, Calvo JR, Osuna C, Rubio A, Guerrero JM: Melatonin potentiates cyclic AMP production stimulated by vasoactive intestinal peptide in human lymphocytes. Neurosci Lett 1992;136:150-152.
58. Del Zar MM, Martinuzzo M, Cardinali DP, Carrera LO, Vacas MI: Diurnal variation in melatonin effect on adenosine triphosphate and serotonin release by human platelets. Acta Endocrinol 1990; 123:453-458.
59. Martinuzzo M, Del-Zar MM, Cardinali DP, Carreras LO, Vacas MI: Melatonin effect on arachidonic acid metabolism to cyclooxygenase derivatives in human platelets. J Pineal Res 1991;11: 111-115.
60. 3H]-melatonin in human platelets. J Pineal Res 1992;13:60-65.
61. van Vuuren RJ, Pitout MJ, van Aswegen CH, Theron JJ: Putative melatonin receptor in human spermatozoa. Clin Biochem 1992;25:125-127.
62. Steinhilber D, Brungs M, Werz O, Wiesenberg I, Danielsson C, Kahlen JP, Nayeri S, Schrader M, Carlberg C: The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J Biol Chem 1995;270:7037-7040.
63. Wiesenberg I, Missbach M, Kahlen JP, Schrader M, Carlberg C. Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucl Acids Res 1995;23:327-333.
64. Molis TM, Springs LL, Hill SM: Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol Endocrinol 1994;8:1681-1690.
65. Cos S, Blask DE: Melatonin modulates growth factor activity in MCF-7 human breast cancer. J Pineal Res 1994;17:25-32.
66. Muller-Weiland D, Behnke B, Kiipmann K, Krone W: Melatonin inhibits LDL receptor activity and cholesterol synthesis in freshly isolated human mononuclear leukocytes. Biochem Biophys Res Commun 1994;203:416-421.
67. Ebisawa T, Karne S, Lerner MR, Reppert SM: Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci USA 1994;91:6133-6137.
68. Premont RT, Inglese J, Lefkowitz RJ: Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J 1995;9:175-182.
69. Slaugenhaupt SA, Roca AL, Liebert CB, Altherr MR, Gusella J F, Reppert SM: Mapping of the gene for the Mella-melatonin receptor to human chromosome 4 (MTNRlA) and mouse chromosome 8 (Mtnrla). Genomics 1995;27:355-357.
70. Shiu SYW, Ng N, Pang SF: A molecular perspective of the genetic relationships of G-protein coupled melatonin receptor subtypes. J Pineal Res 1996;20:198-204.
71. Reiter RJ: Novel intracellular actions of melatonin: Its relation to reactive oxygen species; in Tang PL, Pang SF, Reiter RJ (eds): Melatonin: A Universal Photoperiodic Signal with Diverse Actions. Front Horm Res. Basel, Karger, 1996, vol 21, pp 160-166.
72. Reiter RJ, Melchiorri D, Sewerynek E, Poeggeler B, Barlow-Walden L, Chuang J, Ortiz GG, Acuna-Castroviejo D: A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995;18:1-11.
73. Tang PL, Chan TY, Qian ZM: Melatonin as an antioxidant: An assessment of its properties in vitro; in Tang PL, Pang SF, Reiter RJ (eds): Melatonin: A Universal Photoperiodic Signal with Diverse Actions. Front Horm Res. Basel, Karger, 1996, vol 21, pp 167-173.